Published in Crit Care Med on April 22, 2017
Systemic delivery of bone marrow-derived mesenchymal stem cells to the infarcted myocardium: feasibility, cell migration, and body distribution. Circulation (2003) 5.20
Intracardiac fluid forces are an essential epigenetic factor for embryonic cardiogenesis. Nature (2003) 5.05
Allogeneic mesenchymal stem cell transplantation in postinfarcted rat myocardium: short- and long-term effects. Circulation (2005) 4.03
Survival and development of neonatal rat cardiomyocytes transplanted into adult myocardium. J Mol Cell Cardiol (2002) 3.79
The Princeton III Consensus recommendations for the management of erectile dysfunction and cardiovascular disease. Mayo Clin Proc (2012) 3.45
A randomized, double-blinded, placebo-controlled multicenter trial of adenosine as an adjunct to reperfusion in the treatment of acute myocardial infarction (AMISTAD-II). J Am Coll Cardiol (2005) 3.15
Absence of CuZn superoxide dismutase leads to elevated oxidative stress and acceleration of age-dependent skeletal muscle atrophy. Free Radic Biol Med (2006) 3.04
Sexual activity and cardiovascular disease: a scientific statement from the American Heart Association. Circulation (2012) 2.78
No-reflow phenomenon. Circulation (2002) 2.30
Translational systems biology of inflammation. PLoS Comput Biol (2008) 2.15
Cardiovascular effects of cocaine. Circulation (2010) 2.05
Air pollution and cardiovascular injury epidemiology, toxicology, and mechanisms. J Am Coll Cardiol (2008) 2.02
The embryonic vertebrate heart tube is a dynamic suction pump. Science (2006) 1.96
Four-dimensional cardiac imaging in living embryos via postacquisition synchronization of nongated slice sequences. J Biomed Opt (2005) 1.93
Thickening of the infarcted wall by collagen injection improves left ventricular function in rats: a novel approach to preserve cardiac function after myocardial infarction. J Am Coll Cardiol (2005) 1.83
Sexual dysfunction and cardiac risk (the Second Princeton Consensus Conference). Am J Cardiol (2005) 1.83
Rapid three-dimensional imaging and analysis of the beating embryonic heart reveals functional changes during development. Dev Dyn (2006) 1.68
Comparison of automated oscillometric versus auscultatory blood pressure measurement. Am J Cardiol (2010) 1.66
New horizons in cardioprotection: recommendations from the 2010 National Heart, Lung, and Blood Institute Workshop. Circulation (2011) 1.66
Prognostic utility of erectile dysfunction for cardiovascular disease in younger men and those with diabetes. Am Heart J (2012) 1.65
Reversing blood flows act through klf2a to ensure normal valvulogenesis in the developing heart. PLoS Biol (2009) 1.59
Influence of microcalcifications on vulnerable plaque mechanics using FSI modeling. J Biomech (2008) 1.55
The second Princeton consensus on sexual dysfunction and cardiac risk: new guidelines for sexual medicine. J Sex Med (2006) 1.53
Left ventricular remodeling in the post-infarction heart: a review of cellular, molecular mechanisms, and therapeutic modalities. Heart Fail Rev (2011) 1.49
Washout of transplanted cells from the heart: a potential new hurdle for cell transplantation therapy. Cardiovasc Res (2005) 1.48
Effects of sildenafil on myocardial infarct size, microvascular function, and acute ischemic left ventricular dilation. Cardiovasc Res (2003) 1.47
The "no-reflow" phenomenon: basic science and clinical correlates. Heart (2002) 1.46
The combined use of ibutilide as an active control with intensive electrocardiographic sampling and signal averaging as a sensitive method to assess the effects of tadalafil on the human QT interval. J Am Coll Cardiol (2005) 1.46
Transplantation of neonatal cardiomyocytes after permanent coronary artery occlusion increases regional blood flow of infarcted myocardium. J Mol Cell Cardiol (2003) 1.46
The effects of amlodipine compared to losartan in patients with mild to moderately severe hypertension. J Clin Hypertens (Greenwich) (2003) 1.44
High-risk percutaneous coronary intervention with the TandemHeart and Impella devices: a single-center experience. J Invasive Cardiol (2011) 1.43
Quality assurance of PASADENA hyperpolarization for 13C biomolecules. MAGMA (2008) 1.41
Mechanistic simulations of inflammation: current state and future prospects. Math Biosci (2008) 1.40
Clinical cardiology: physician update: erectile dysfunction and cardiovascular disease. Circulation (2011) 1.39
Rotational atherectomy in the drug-eluting stent era: a single-center experience. J Invasive Cardiol (2011) 1.38
Late sodium current inhibition as a new cardioprotective approach. J Mol Cell Cardiol (2008) 1.35
The no-reflow phenomenon: A basic mechanism of myocardial ischemia and reperfusion. Basic Res Cardiol (2006) 1.32
Rebuilding a damaged heart: long-term survival of transplanted neonatal rat cardiomyocytes after myocardial infarction and effect on cardiac function. Circulation (2002) 1.32
Flow patterns generated by oblate medusan jellyfish: field measurements and laboratory analyses. J Exp Biol (2005) 1.31
Metabolic syndrome and robustness tradeoffs. Diabetes (2004) 1.31
Promise of blood- and bone marrow-derived stem cell transplantation for functional cardiac repair: putting it in perspective with existing therapy. J Am Coll Cardiol (2009) 1.29
A 4-year update on the safety of sildenafil citrate (Viagra). Urology (2002) 1.28
WNT1 mutations in families affected by moderately severe and progressive recessive osteogenesis imperfecta. Am J Hum Genet (2013) 1.27
Coronary no-reflow phenomenon: from the experimental laboratory to the cardiac catheterization laboratory. Catheter Cardiovasc Interv (2008) 1.24
Survival and maturation of human embryonic stem cell-derived cardiomyocytes in rat hearts. J Mol Cell Cardiol (2007) 1.23
Coronary no-flow and ventricular tachycardia associated with habitual marijuana use. Ann Emerg Med (2003) 1.22
Hypothermia during reperfusion limits 'no-reflow' injury in a rabbit model of acute myocardial infarction. Cardiovasc Res (2003) 1.20
Hydrodynamic stability of swimming in ostraciid fishes: role of the carapace in the smooth trunkfish Lactophrys triqueter (Teleostei: Ostraciidae). J Exp Biol (2003) 1.19
Echocardiographic particle image velocimetry: a novel technique for quantification of left ventricular blood vorticity pattern. J Am Soc Echocardiogr (2010) 1.17
The role of optimal vortex formation in biological fluid transport. Proc Biol Sci (2005) 1.17
Left ventricular form and function: scientific priorities and strategic planning for development of new views of disease. Circulation (2004) 1.16
Therapeutic potential of phosphodiesterase 5 inhibition for cardiovascular disease. Circulation (2003) 1.16
An update on cardioprotection: a review of the latest adjunctive therapies to limit myocardial infarction size in clinical trials. J Am Coll Cardiol (2012) 1.16
Alterations in myostatin expression are associated with changes in cardiac left ventricular mass but not ejection fraction in the mouse. J Endocrinol (2007) 1.14
Cardiac uses of phosphodiesterase-5 inhibitors. J Am Coll Cardiol (2012) 1.13
Coronary no reflow. J Mol Cell Cardiol (2011) 1.12
A reducing redox environment promotes C2C12 myogenesis: implications for regeneration in aged muscle. Cell Biol Int (2006) 1.11
Review of vascular closure devices. J Invasive Cardiol (2010) 1.11
Body-induced vortical flows: a common mechanism for self-corrective trimming control in boxfishes. J Exp Biol (2005) 1.10
Donation after cardiac death and the anesthesiologist. Anesth Analg (2010) 1.08
Rules of engagement. Nature (2007) 1.08
Role of a paracrine action of mesenchymal stem cells in the improvement of left ventricular function after coronary artery occlusion in rats. Regen Med (2007) 1.08
Architecture, constraints, and behavior. Proc Natl Acad Sci U S A (2011) 1.07
Structure function interface with sequential shortening of basal and apical components of the myocardial band. Eur J Cardiothorac Surg (2005) 1.07
Comments on Defining the Contribution of Diastolic Vortex Ring to Left Ventricular Filling. J Am Coll Cardiol (2015) 1.06
Transgenic expression of dominant negative tuberin through a strong constitutive promoter results in a tissue-specific tuberous sclerosis phenotype in the skin and brain. J Biol Chem (2004) 1.04
Genetic contributors toward increased risk for ischemic heart disease. J Mol Cell Cardiol (2005) 1.04
Sporting events affect spectators' cardiovascular mortality: it is not just a game. Am J Med (2010) 1.03
Ranolazine, an antianginal agent, markedly reduces ventricular arrhythmias induced by ischemia and ischemia-reperfusion. Am J Physiol Heart Circ Physiol (2009) 1.02
On mitral valve dynamics and its connection to early diastolic flow. Ann Biomed Eng (2008) 1.02
Motifs, control, and stability. PLoS Biol (2005) 1.02
Flow Patterns Around the Carapaces of Rigid-bodied, Multi-propulsor Boxfishes (Teleostei: Ostraciidae). Integr Comp Biol (2002) 1.01
No-reflow phenomenon persists long-term after ischemia/reperfusion in the rat and predicts infarct expansion. Circulation (2003) 1.00
Long-term outcome of fetal cell transplantation on postinfarction ventricular remodeling and function. J Mol Cell Cardiol (2003) 1.00
Cellular cardiomyoplasty of cardiac fibroblasts by adenoviral delivery of MyoD ex vivo: an unlimited source of cells for myocardial repair. Circulation (2002) 0.99
Mesenchymal stem cell administration at coronary artery reperfusion in the rat by two delivery routes: a quantitative assessment. Life Sci (2008) 0.99
Microvascular reperfusion injury: rapid expansion of anatomic no reflow during reperfusion in the rabbit. Am J Physiol Heart Circ Physiol (2002) 0.99
Relationship between no reflow and infarct size as influenced by the duration of ischemia and reperfusion. Am J Physiol Heart Circ Physiol (2002) 0.99
Peripheral chronic total occlusions treated with subintimal angioplasty and a true lumen re-entry device. J Invasive Cardiol (2009) 0.98
A role for endothelin in neuropathic pain after chronic constriction injury of the sciatic nerve. Anesth Analg (2005) 0.98
Critical role of nuclear calcium/calmodulin-dependent protein kinase IIdeltaB in cardiomyocyte survival in cardiomyopathy. J Biol Chem (2009) 0.98
No-reflow phenomenon following percutaneous coronary intervention for acute myocardial infarction: incidence, outcome, and effect of pharmacologic therapy. J Interv Cardiol (2010) 0.97
Diagnosis and treatment of erectile dysfunction for reduction of cardiovascular risk. J Urol (2013) 0.97
Circumferential strain in the wall of the common carotid artery: comparing displacement-encoded and cine MRI in volunteers. Magn Reson Med (2008) 0.96
Cocaine-induced acute myocardial infarction. Clin Med Res (2007) 0.96
Testosterone and the cardiovascular system: a comprehensive review of the basic science literature. J Am Heart Assoc (2013) 0.96
Delivering stem cells to the heart in a collagen matrix reduces relocation of cells to other organs as assessed by nanoparticle technology. Regen Med (2009) 0.95
Transthoracic echocardiography in rats. Evalution of commonly used indices of left ventricular dimensions, contractile performance, and hypertrophy in a genetic model of hypertrophic heart failure (SHHF-Mcc-facp-Rats) in comparison with Wistar rats during aging. Basic Res Cardiol (2003) 0.95
Sildenafil in patients with cardiovascular disease. Am J Cardiol (2003) 0.93
Drug interactions with phosphodiesterase-5 inhibitors used for the treatment of erectile dysfunction or pulmonary hypertension. Circulation (2010) 0.93
Cardioprotection of insulin-like growth factor-1 during reperfusion therapy: what is the underlying mechanism or mechanisms? Circ Cardiovasc Interv (2011) 0.93
Sod2 overexpression preserves myoblast mitochondrial mass and function, but not muscle mass with aging. Aging Cell (2009) 0.93
Particulate air pollution and coronary heart disease. Curr Opin Cardiol (2009) 0.93
Real-time intravascular shear stress in the rabbit abdominal aorta. IEEE Trans Biomed Eng (2009) 0.93
The gap junction uncoupler heptanol abrogates infarct size reduction with preconditioning in mouse hearts. Cardiovasc Pathol (2002) 0.92
Optimal data systems: the future of clinical predictions and decision support. Curr Opin Crit Care (2014) 0.92
Ischemic preconditioning maintains cardioprotection in aging normotensive and spontaneously hypertensive rats. Exp Gerontol (2009) 0.92
Mild hypothermia as a cardioprotective approach for acute myocardial infarction: laboratory to clinical application. J Cardiovasc Pharmacol Ther (2010) 0.92
Cellular cardiomyoplasty--cardiomyocytes, skeletal myoblasts, or stem cells for regenerating myocardium and treatment of heart failure? Cardiovasc Res (2003) 0.92